CXCR4 and glioma: Although, there are reports about targeting CXCR4 in combination with current treatment regimens available for GBM patientsnone have utilized the shRNA mediated inhibition of the CXCR4 gene on glioma cells in order to understand its in-vivo role in glioma's perivascular invasion [26–28].